Becker's Healthcare January 18, 2024
The American Nurses Association has come out in support of the federal government’s efforts to reconsider the drug classification for marijuana, the organization announced Jan. 18.
The drug is currently classified as a Schedule 1 substance, which is assigned to the most dangerous drugs like heroin, ecstasy and LSD. In 2022 the Biden administration began taking steps with the HHS to reevaluate how marijuana was classified. This led to an August 2023 recommendation from HHS Assistant Secretary of Health Rachel Levine, MD, for the Drug Enforcement Administration to reclassify marijuana as a Schedule 3 substance, finding it poses less risk than other Schedule 1 substances.
Among the most recent developments, the FDA released a 252-page review Jan. 12, along...